论文部分内容阅读
To the Editor: We thank Dr. Braillon for the thoughtful remarks regarding prognostic impact of interleukin (IL)-26 on patients with hepatocellular carcinoma (HCC) undergoing surgical resection [1]. This study drew a conclusion that relative high expressio